Get the Stockscreener App
2.50
4.17%
0.10
After Hours:
2.50
Anavex Life Sciences Corp Stock (AVXL) Forecast
The Anavex Life Sciences Corp (AVXL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.05, representing a +461.88% increase from the current price of $2.50. The highest analyst price target is $16.64, and the lowest is $11.46.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AVXL Price Target
Average 21.05
(+741.86% Upside)
Is Anavex Life Sciences Corp (AVXL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.55 | Neutral |
| STOCH(9,6) | 55.76 | Neutral |
| STOCHRSI(14) | 78.23 | Neutral |
| MACD(12,26) | -0.0579 | Buy |
| ADX(14) | 15.58 | Neutral |
| William %R | -54.21 | Neutral |
| CCI(14) | -8.8892 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4565
Buy
|
2.4823
Buy
|
| MA20 |
2.5358
Sell
|
2.5188
Sell
|
| MA50 |
2.6291
Sell
|
2.7008
Sell
|
| MA100 |
3.1148
Sell
|
3.1702
Sell
|
| MA200 |
4.1886
Sell
|
4.4466
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, AVXL could be considered a Moderate Sell, with 17 technical analysis indicators signaling 3 Buy signals, 8 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on AVXL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.55 indicates that AVXL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.76 indicates that AVXL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.23 indicates that AVXL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.58 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -8.8892 indicates that AVXL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term AVXL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Anavex Life Sciences Corp financial reports and earnings history, Anavex Life Sciences Corp (AVXL) stock could reach $5.1516 by 2030, $10.69 by 2040 and $16.72 by 2050. See the projected annual prices until 2050 of the Anavex Life Sciences Corp stock below:
- Anavex Life Sciences Corp (AVXL) is expected to reach an average price of $8.4808 in 2035, with a high prediction of $8.9508 and a low estimate of $6.5976. This indicates an $239.23% rise from the last recorded price of $2.50.
- Anavex Life Sciences Corp (AVXL) stock is projected to chart a bullish course in 2040, with an average price target of $10.22, representing an $308.63% surge from its current level. The forecast ranges from a conservative $9.5134 to a sky-high $10.69.
- Our analysts predict Anavex Life Sciences Corp (AVXL) to jump 429.02% by 2045, soaring from $11.58 to an average price of $13.23, potentially reaching $13.87. While $11.58 is the low estimate, the potential upside is significant.
- Anavex Life Sciences Corp (AVXL) stock is expected to climb by 2050, reaching an average of $16.43, a $557.16% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.72 and $13.22, respectively, highlighting the market's uncertainty.
Anavex Life Sciences Corp Stock (AVXL) Year by Year Forecast
Anavex Life Sciences Corp Stock (AVXL) Price Forecast for 2026
The predicted value for Anavex Life Sciences Corp (AVXL) in 2026 is set at an average of $18.65. Estimates vary from a peak of $32.15 to a trough of $5.1519, indicating an +646.01% surge from the present price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $16.15 | $11.46 | $16.64 | +545.90% |
| September, 2026 | $25.72 | $17.35 | $32.15 | +928.78% |
| October, 2026 | $20.00 | $18.02 | $27.51 | +700.02% |
| November, 2026 | $20.14 | $18.22 | $21.62 | +705.71% |
| December, 2026 | $18.60 | $17.20 | $21.30 | +644.19% |
Anavex Life Sciences Corp Stock (AVXL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Anavex Life Sciences Corp (AVXL) is $16.09, with a high forecast of $24.39 and a low forecast of $7.7993. This indicates an +543.74% increase from the last price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.51 | $17.35 | $19.10 | +640.25% |
| February, 2027 | $20.90 | $17.89 | $24.39 | +735.91% |
| March, 2027 | $18.80 | $16.91 | $21.96 | +651.99% |
| April, 2027 | $15.05 | $14.09 | $20.49 | +502.06% |
| May, 2027 | $11.09 | $10.59 | $14.89 | +343.72% |
| June, 2027 | $11.03 | $9.9442 | $13.94 | +341.40% |
| July, 2027 | $12.98 | $10.56 | $14.06 | +419.06% |
| August, 2027 | $10.30 | $10.28 | $13.67 | +311.93% |
| September, 2027 | $10.38 | $7.7993 | $10.50 | +315.21% |
| October, 2027 | $9.1417 | $8.0317 | $10.47 | +265.67% |
| November, 2027 | $13.45 | $9.3821 | $13.77 | +438.13% |
| December, 2027 | $12.33 | $10.32 | $14.06 | +393.01% |
Anavex Life Sciences Corp Stock (AVXL) Price Forecast for 2028
In 2028, Anavex Life Sciences Corp (AVXL) is projected to reach an average price of $12.03, with a high projection of $15.92 and a low estimate of $8.1311. This indicates an +381.06% rise from the last price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.8969 | $9.8669 | $12.65 | +295.88% |
| February, 2028 | $11.00 | $9.5485 | $11.34 | +339.94% |
| March, 2028 | $12.85 | $10.74 | $14.02 | +414.02% |
| April, 2028 | $12.57 | $11.65 | $15.92 | +402.88% |
| May, 2028 | $9.134 | $8.3132 | $13.91 | +265.36% |
| June, 2028 | $10.99 | $8.6944 | $12.02 | +339.42% |
| July, 2028 | $11.23 | $10.53 | $12.61 | +349.09% |
| August, 2028 | $9.6692 | $9.2242 | $11.41 | +286.77% |
| September, 2028 | $8.4807 | $8.3757 | $10.55 | +239.23% |
| October, 2028 | $9.1323 | $8.1311 | $9.3223 | +265.29% |
| November, 2028 | $9.8343 | $8.7127 | $10.42 | +293.37% |
| December, 2028 | $8.8259 | $8.5659 | $10.86 | +253.04% |
Anavex Life Sciences Corp Stock (AVXL) Price Forecast for 2029
The 2029 price forecast for Anavex Life Sciences Corp Stock (AVXL) is $7.5614 on average, with a high prediction of $11.16 and a low estimate of $3.9653. This represents an +202.45% increase from the previous price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.9479 | $8.3176 | $9.4367 | +257.92% |
| February, 2029 | $8.7395 | $8.2793 | $10.59 | +249.58% |
| March, 2029 | $8.2711 | $8.2511 | $9.091 | +230.84% |
| April, 2029 | $6.7526 | $6.5026 | $8.6214 | +170.11% |
| May, 2029 | $6.4446 | $5.6034 | $6.9746 | +157.78% |
| June, 2029 | $8.2762 | $6.175 | $8.3262 | +231.05% |
| July, 2029 | $10.02 | $8.2866 | $11.16 | +300.71% |
| August, 2029 | $6.6798 | $6.459 | $7.6582 | +167.19% |
| September, 2029 | $5.6314 | $5.5814 | $6.861 | +125.25% |
| October, 2029 | $5.3733 | $5.3433 | $6.2861 | +114.93% |
| November, 2029 | $4.4949 | $4.3149 | $5.9137 | +79.80% |
| December, 2029 | $4.29 | $3.9653 | $4.6253 | +71.60% |
Anavex Life Sciences Corp Stock (AVXL) Price Forecast for 2030
Anavex Life Sciences Corp Stock (AVXL) is expected to reach an average price of $5.4858 in 2030, with a high forecast of $7.5456 and a low forecast of $3.4261. This signifies an +119.43% surge from the last price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.244 | $4.0524 | $5.1516 | +69.76% |
| February, 2030 | $4.4371 | $4.1948 | $5.2963 | +77.49% |
| March, 2030 | $3.6353 | $3.5703 | $4.5179 | +45.41% |
| April, 2030 | $3.83 | $3.4261 | $4.1435 | +53.20% |
| May, 2030 | $4.3702 | $3.7843 | $4.8566 | +74.81% |
| June, 2030 | $3.9806 | $3.8598 | $4.5482 | +59.22% |
| July, 2030 | $3.5596 | $3.5238 | $4.183 | +42.38% |
| August, 2030 | $3.6477 | $3.4812 | $4.6762 | +45.91% |
| September, 2030 | $4.2209 | $3.5785 | $4.2909 | +68.84% |
| October, 2030 | $6.2249 | $3.9933 | $6.6149 | +148.99% |
| November, 2030 | $3.893 | $3.788 | $7.5456 | +55.72% |
| December, 2030 | $3.8412 | $3.4488 | $4.7004 | +53.65% |
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):